Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16755 publications

Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers.

Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers.

Journal: Future oncology (London, England)
Published: October 18, 2025

Correction: Pathologic Complete Response Achieved in Early-Stage HER2-Positive Breast Cancer After Neoadjuvant Therapy With Trastuzumab and Chemotherapy vs. Trastuzumab, Chemotherapy, and Pertuzumab: A Systematic Review and Meta-Analysis of Clinical Trials.

Correction: Pathologic Complete Response Achieved in Early-Stage HER2-Positive Breast Cancer After Neoadjuvant Therapy With Trastuzumab and Chemotherapy vs. Trastuzumab, Chemotherapy, and Pertuzumab: A Systematic Review and Meta-Analysis of Clinical Trials.

Journal: Cureus
Published: October 17, 2025

Harnessing genomic profiling for improved Urothelial cancer outcomes.

Harnessing genomic profiling for improved Urothelial cancer outcomes.

Journal: Expert review of anticancer therapy
Published: October 15, 2025

Gastric Carcinoma: Diagnosis, Staging, and Treatment.

Gastric Carcinoma: Diagnosis, Staging, and Treatment.

Journal: Deutsches Arzteblatt international
Published: October 14, 2025

Efficacy and Safety of Antibody Drug Conjugates in Previously Treated Hormone Receptor Positive HER2 Negative (or Low) Metastatic Breast Cancer-A Systematic Review and Meta-Analysis.

Efficacy and Safety of Antibody Drug Conjugates in Previously Treated Hormone Receptor Positive HER2 Negative (or Low) Metastatic Breast Cancer-A Systematic Review and Meta-Analysis.

Journal: American journal of clinical oncology
Published: October 14, 2025

Development and evaluation of targeted liposomes for improved doxorubicin and quercetin delivery for MDR breast cancer.

Development and evaluation of targeted liposomes for improved doxorubicin and quercetin delivery for MDR breast cancer.

Journal: Therapeutic delivery
Published: October 14, 2025

Supramolecular Chemistry Enables Radiolabeling of Proteins under Mild Conditions.

Supramolecular Chemistry Enables Radiolabeling of Proteins under Mild Conditions.

Journal: Molecular pharmaceutics
Published: October 13, 2025

Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer.

Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer.

Journal: Danish medical journal
Published: October 10, 2025

Pathological response of breast cancer to neoadjuvant chemotherapy at a single tertiary centre.

Pathological response of breast cancer to neoadjuvant chemotherapy at a single tertiary centre.

Journal: South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie
Published: October 07, 2025

Next-generation sequencing in breast cancer: current clinical applications and future directions.

Next-generation sequencing in breast cancer: current clinical applications and future directions.

Journal: Annals of medicine
Published: October 06, 2025

ASCORBYL PALMITATE ENHANCES ANTI-PROLIFERATIVE EFFECT OF TRASTUZUMAB IN HER2-POSITIVE BREAST CANCER CELLS.

ASCORBYL PALMITATE ENHANCES ANTI-PROLIFERATIVE EFFECT OF TRASTUZUMAB IN HER2-POSITIVE BREAST CANCER CELLS.

Journal: Experimental oncology
Published: October 06, 2025

Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin.

Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin.

Journal: JCO precision oncology
Published: October 02, 2025
Showing 1-12 of 16,755

Last Updated: 10/31/2025